About
Paradox Immunotherapeutics is a biotech company developing monoclonal antibody therapies that selectively target misfolded proteins to treat protein misfolding diseases such as amyloidosis and neurodegenerative disorders.
Explore Paradox Immunotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.